Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lies Langouche

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Best Practice & Research. Clinical Anaesthesiology|January 30, 2010
Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulinIlse Vanhorebeek, Lies Langouche
Critical Care Medicine|April 17, 2014
The authors replyMichael P Casaer, Lies Langouche
Critical Care Medicine|November 9, 2012
Endocrine, metabolic, and morphologic alterations of adipose tissue during critical illnessMirna B Marques, Lies Langouche
Critical Care Clinics|January 10, 2006
Glucose metabolism and insulin therapyLies Langouche, Greet Van den Berghe
Handbook of Clinical Neurology|September 25, 2014
Hypothalamic-pituitary hormones during critical illness: a dynamic neuroendocrine responseLies Langouche, Greet Van den Berghe
Peptides|July 20, 2002
Structure-activity relationship and signal transduction of gamma-MSH peptides in GH3 cells: further evidence for a new melanocortin receptorLies Langouche, Katrien Pals, Carl Denef
Intensive Care Medicine|December 16, 2025
A new era for ICU-acquired weakness research-from mechanisms to meaningful recoverySimone Piva, Lies Langouche, Aabdi Mohammed
Endocrinology and Metabolism Clinics of North America|November 28, 2006
The dynamic neuroendocrine response to critical illnessLies Langouche, Greet Van den Berghe
Current Opinion in Critical Care|January 25, 2026
Abnormalities of liver function during critical illnessPhilippe Meersseman, Alexander Wilmer, Lies Langouche
Intensive Care Medicine Experimental|November 28, 2023
Impact of critical illness on cholesterol and fatty acids: insights into pathophysiology and therapeutic targetsCaroline Lauwers, Lauren De Bruyn, Lies Langouche
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Best Practice & Research. Clinical Anaesthesiology|January 30, 2010
Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulinIlse Vanhorebeek, Lies Langouche
Critical Care Medicine|April 17, 2014
The authors replyMichael P Casaer, Lies Langouche
Critical Care Medicine|November 9, 2012
Endocrine, metabolic, and morphologic alterations of adipose tissue during critical illnessMirna B Marques, Lies Langouche
Critical Care Clinics|January 10, 2006
Glucose metabolism and insulin therapyLies Langouche, Greet Van den Berghe
Handbook of Clinical Neurology|September 25, 2014
Hypothalamic-pituitary hormones during critical illness: a dynamic neuroendocrine responseLies Langouche, Greet Van den Berghe
Peptides|July 20, 2002
Structure-activity relationship and signal transduction of gamma-MSH peptides in GH3 cells: further evidence for a new melanocortin receptorLies Langouche, Katrien Pals, Carl Denef
Intensive Care Medicine|December 16, 2025
A new era for ICU-acquired weakness research-from mechanisms to meaningful recoverySimone Piva, Lies Langouche, Aabdi Mohammed
Endocrinology and Metabolism Clinics of North America|November 28, 2006
The dynamic neuroendocrine response to critical illnessLies Langouche, Greet Van den Berghe
Current Opinion in Critical Care|January 25, 2026
Abnormalities of liver function during critical illnessPhilippe Meersseman, Alexander Wilmer, Lies Langouche
Intensive Care Medicine Experimental|November 28, 2023
Impact of critical illness on cholesterol and fatty acids: insights into pathophysiology and therapeutic targetsCaroline Lauwers, Lauren De Bruyn, Lies Langouche
Pageof 11